Trial intelligence / Profile preview

Valsalva maneuver and tourniquet closure for propofol injection pain

IRCT20160307026950N28Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of propofol, sponsored by Isfahan University of Medical Sciences. Primary endpoint: Propofol injection pain intensity. Started Dec 2020; status: completed.

02

Drugs

propofol

Beyond the preview

Go deeper on IRCT20160307026950N28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160307026950N28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call